OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General…
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance
Publication of Circular for Combined Annual General Meeting of
September 30, 2025
Nantes, September 9, 2025, 8:30 p.m. CET – OSE Immunotherapeutics SA (I… [12692 chars]
Source: GlobeNewswire | Published: 2025-09-09T00:00:00Z
Read original article on GlobeNewswire
Credit: GlobeNewswire
